The Ristocetin Cofactor Test is a specialized diagnostic assay designed to evaluate the functionality of the von Willebrand factor (vWF), a crucial protein involved in blood clotting. This test is particularly useful in diagnosing von Willebrand Disease (vWD), a genetic disorder that affects the blood's ability to clot properly, leading to excessive bleeding. During the test, ristocetin, an antibiotic, is added to a sample of the patient's blood to stimulate platelet aggregation in a manner that mimics the natural clotting process. The effectiveness of this interaction reflects the functionality of the vWF and helps in diagnosing vWD as well as differentiating it from other clotting disorders.
In the United Arab Emirates, DNA Labs UAE offers the Ristocetin Cofactor Test, providing a reliable and accurate assessment for individuals suspected of having clotting abnormalities. The test is priced at 3090 AED, reflecting the specialized nature of the assay and the detailed, comprehensive insights it provides into the patient's clotting profile. Patients seeking this test at DNA Labs UAE can expect professional service, with results that play a critical role in the diagnosis and management of von Willebrand Disease and related clotting disorders.
The "Biopsy Breast Modified Radical Mastectomy ER PR HER2NEU KI67 Test" is a comprehensive diagnostic evaluation performed on breast tissue samples, typically obtained during a modified radical mastectomy. This type of mastectomy involves the surgical removal of the breast tissue and some of the lymph nodes under the arm while sparing the chest muscles. The test focuses on analyzing several critical biomarkers that are pivotal in understanding breast cancer characteristics and guiding treatment strategies.
1. **ER (Estrogen Receptor)**: This test measures the presence of estrogen receptors in the cancer cells. Breast cancers that are ER-positive depend on estrogen to grow, and treatments that lower estrogen levels or block estrogen receptors can be effective.
2. **PR (Progesterone Receptor)**: Similar to the ER test, this evaluates the presence of progesterone receptors in the cancer cells. PR-positive cancers can also be treated with hormone-blocking therapies.
3. **HER2/neu**: HER2 is a protein that promotes the growth of cancer cells. In about one of every five breast cancers, the cancer cells make an excess of HER2 due to a gene mutation. HER2-positive breast cancers may be more aggressive but may respond to targeted therapies.
4. **Ki-67**: This is a marker of cell proliferation. Ki-67 levels indicate how quickly breast cancer cells are dividing and growing. Higher levels of Ki-67 suggest a more aggressive cancer that may respond differently to certain treatments.
The test is conducted at DNA Labs UAE, a leading laboratory known for its advanced diagnostic capabilities. The cost of this comprehensive analysis is 3090 AED. By assessing these markers, healthcare providers can tailor a more precise and effective treatment plan for breast cancer patients, enhancing the chances of a successful outcome. This test is crucial for making informed decisions about hormone therapy, chemotherapy, and targeted therapy, thereby significantly impacting the patient's treatment journey and prognosis.
The "MDS Panel Cytogenetics and FISH del5q del7q del20q Test" is a sophisticated diagnostic tool used in the evaluation of myelodysplastic syndromes (MDS), a group of diverse bone marrow disorders characterized by ineffective hematopoiesis leading to blood cell abnormalities. This test specifically targets the detection of deletions in chromosomes 5q, 7q, and 20q, which are common cytogenetic abnormalities associated with MDS. By employing cytogenetic analysis alongside Fluorescence In Situ Hybridization (FISH) techniques, this panel provides a comprehensive genetic profile of the patient's condition, aiding in accurate diagnosis, prognosis, and the formulation of an effective treatment strategy.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test ensures high-quality results through advanced technology and expert interpretation. The cost of the test is set at 2550 AED, reflecting the intricate procedures and the detailed, reliable insights it offers into the genetic underpinnings of MDS. By identifying specific chromosomal deletions, healthcare providers can better understand the severity and progression of the disease, enabling tailored therapeutic interventions and monitoring strategies. This test represents a critical step in the management of MDS, offering hope for improved patient outcomes through precision medicine.
The Bas-Congo Virus and Heartland Virus Multiplex Detection and Differentiation Viral Load Quantitative Test is a sophisticated diagnostic tool available at DNA Labs UAE. This test is designed to accurately identify and differentiate between the Bas-Congo virus (BASV) and Heartland virus (HRTV), two emerging pathogens that can cause severe illness in humans. Using cutting-edge molecular techniques, the test quantifies the viral load in a patient's sample, providing crucial information for the diagnosis, treatment, and monitoring of these infections.
The Bas-Congo virus, discovered in the Democratic Republic of Congo, is associated with acute febrile illness, while the Heartland virus, identified in the United States, is linked to tick-borne disease presenting with fever, fatigue, and leukopenia. Given their potential for significant health impact, rapid and accurate detection of these viruses is essential for effective patient management and controlling the spread of disease.
The test is conducted at DNA Labs UAE, a leading facility in the region known for its advanced diagnostic capabilities and commitment to high-quality healthcare services. With a test cost of 2550 AED, patients and healthcare providers can access a reliable and precise method for assessing the presence and load of these viruses, enabling timely and appropriate medical interventions.
The "Bacterial Pneumonia Multiplex RNA Detection Qualitative Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify multiple bacteria responsible for causing pneumonia through the qualitative analysis of RNA. This test leverages advanced molecular techniques to detect the presence of RNA from various bacteria known to cause pneumonia, providing a comprehensive assessment in a single examination. The cost of this test is set at 2890 AED.
This test is particularly useful in clinical settings where rapid and accurate identification of the bacterial cause is crucial for the timely management and treatment of pneumonia. By targeting RNA, the test ensures high sensitivity and specificity, making it an effective option for diagnosing bacterial pneumonia. The multiplex aspect of the test allows for the simultaneous detection of several pathogens, streamlining the diagnostic process and aiding in the selection of appropriate antimicrobial therapy.
Performed at DNA Labs UAE, a facility known for its cutting-edge diagnostic technologies and expertise in molecular diagnostics, this test represents a significant advancement in the field of infectious disease diagnostics. Patients and healthcare providers can expect reliable and prompt results, contributing to improved patient outcomes in cases of bacterial pneumonia.
The "Interleukin-6 (IL-6) SARS-CoV-2 Advanced Panel Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to provide critical insights into a patient's immune response to SARS-CoV-2, the virus responsible for COVID-19. Priced at 3280 AED, this test specifically measures the levels of Interleukin-6 (IL-6), a cytokine that plays a pivotal role in the immune system's response to infections and inflammation. Elevated levels of IL-6 are associated with severe inflammatory responses and can be indicative of a severe or critical progression of COVID-19. By assessing IL-6 levels in conjunction with other markers, this advanced panel test aids healthcare providers in making informed decisions regarding patient management, potential therapeutic interventions, and prognosis. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a vital resource for clinicians in the ongoing battle against COVID-19, offering a deeper understanding of the disease's impact on the immune system.
The "LPL Expert Panel 2 Test" is a specialized genetic screening offered by DNA Labs UAE, designed to assess variations in the Lipoprotein Lipase (LPL) gene. This gene plays a crucial role in lipid metabolism, and mutations can lead to disorders such as familial chylomicronemia. By analyzing specific genetic markers, the test aims to identify individuals at risk of developing related conditions, enabling proactive health management strategies. Priced at 3280 AED, this comprehensive analysis is a valuable tool for those seeking to understand their genetic predisposition to lipid metabolism disorders and take informed steps towards personalized healthcare.
The Metal Screen 3 Urine Test, available at DNA Labs UAE for a cost of 3280 AED, is a comprehensive diagnostic tool designed to detect and quantify the presence of metals in the body. This test is particularly useful for individuals who are exposed to heavy metals in their environment or workplace, or for those who suspect metal toxicity as a cause of their health issues. By analyzing a urine sample, the test can identify a range of metals including, but not limited to, lead, mercury, cadmium, and arsenic. The results from this test can provide valuable insights into one's exposure levels and potential health risks, guiding healthcare professionals in formulating a suitable treatment or intervention plan. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable results for this crucial health assessment.
Preimplantation Genetic Screening (PGS), also known as Preimplantation Genetic Testing for Aneuploidies (PGT-A), is a cutting-edge procedure that is performed on embryos produced through in vitro fertilization (IVF) before their transfer to the uterus. This test is designed to examine the embryos for any chromosomal abnormalities that could lead to genetic disorders, miscarriage, or failure to implant. By ensuring that only genetically healthy embryos are implanted, PGS aims to increase the chances of a successful pregnancy and the birth of a healthy child.
At DNA Labs UAE, the PGS test is available for a cost of 3280 AED. The facility employs state-of-the-art genetic testing technologies to analyze the chromosomes of embryos with high precision. This screening process involves taking a few cells from each embryo, typically at the blastocyst stage, to evaluate all 23 pairs of chromosomes for any abnormalities. The result of this comprehensive screening aids in selecting the best embryo(s) for transfer, significantly improving the outcomes of IVF treatments. DNA Labs UAE provides expert counseling and support throughout the process, ensuring that couples understand the benefits, limitations, and implications of PGS testing.
The PTH Antibody Test is a specialized diagnostic procedure designed to measure the presence and levels of antibodies against parathyroid hormone (PTH) in the blood. PTH is a critical hormone produced by the parathyroid glands, which plays a vital role in regulating calcium levels within the blood. The presence of antibodies against PTH can interfere with its normal function, leading to various metabolic and bone disorders, including osteoporosis and hypocalcemia.
This test is particularly useful for individuals who exhibit symptoms or have medical conditions that suggest an abnormality in calcium metabolism, potentially due to an autoimmune response against the parathyroid hormone. By detecting these antibodies, healthcare providers can gain valuable insights into the underlying causes of a patient's symptoms, aiding in the diagnosis and management of conditions related to impaired PTH function.
At DNA Labs UAE, the PTH Antibody Test is offered at a cost of 3280 AED. DNA Labs UAE is known for its state-of-the-art facilities and adherence to high standards of laboratory testing. The lab employs advanced diagnostic technologies and methodologies to ensure accurate and reliable test results. Conducting the test in such a reputable facility guarantees that patients receive comprehensive and precise evaluations of their parathyroid function and calcium metabolism, facilitating optimal treatment and management strategies.
